| Literature DB >> 29212962 |
Akane Sato1,2, Borjigin Sarentonglaga1, Kazuko Ogata1,3, Mio Yamaguchi1,4, Asuka Hara1,2, Khurchabiling Atchalalt1,2, Naoko Sugane5, Rika Fukumori1,6, Yoshikazu Nagao1,2.
Abstract
The maturation rate of canine oocytes during in vitro maturation (IVM) needs to be improved. The present study was designed to evaluate the effects of insulin-like growth factor-1 (IGF-1) on the IVM of canine oocytes. Ovaries were obtained by ovariohysterectomy and were sliced to release cumulus-oocyte complexes (COCs). In Experiment 1, the effects of different concentrations of IGF-1 on the nuclear maturation of oocytes was investigated. The COCs were cultured in a modified medium (mTCM199) with IGF-1 (0, 0.5, 5, 10, and 50 µg/ml). At the end of the 48 h culture, oocytes were fixed and stained to evaluate their nuclear stage. Supplementation with 50 µg/ml IGF-1 induced a significantly higher metaphase II (MII) rate (P < 0.05) compared to the 0 and 0.5 μg/ml IGF-1 groups. In Experiment 2, the expression levels of insulin receptor (INSR), IGF-1 receptor (IGF-1R), and IGF-2 receptor (IGF-2R) genes, localized to canine oocytes and cumulus cells, were investigated before and after IVM. The expression level of IGF-1R in cumulus cells after IVM was higher than that before IVM (P < 0.05). In Experiment 3, it was investigated whether an inhibitor of PTEN (phosphatase and tensin homolog), bpV, affects the nuclear maturation of oocytes. Regardless of bpV supplementation at a concentration of 0.2 to 200 µmol/l, there was no significant difference in the proportion of oocytes that reached the MII stage. These results indicated that IGF-1 has a favorable effect on the IVM of canine oocytes, possibly through the stimulation of the Ras/MAPK pathway via IGF-1R expressed in cumulus cells.Entities:
Keywords: Canine oocyte; In vitro maturation; Insulin-like growth factor-1 (IGF-1); Insulin-like growth factor-1 receptor (IGF-1R); bpV
Mesh:
Substances:
Year: 2017 PMID: 29212962 PMCID: PMC5830362 DOI: 10.1262/jrd.2017-145
Source DB: PubMed Journal: J Reprod Dev ISSN: 0916-8818 Impact factor: 2.214
Fig. 1.Chromatin configuration in canine oocytes stained with Hoechst 33342. (A) Oocyte at the germinal vesicle (GV) stage; (B) Oocyte at the germinal vesicle breakdown (GVBD) stage; (C) Oocyte at the metaphase I (MI) stage; (D) Oocyte at the metaphase II (MII) stage. (A), (B) and (C) were single optical sections selected from Z stacks. (D) was a merged image of Z stacks.
Primers used for the quantitative reverse transcription polymerase chain reaction (RT-qPCR)
| Gene | Primer Sequence (5’→3’) | Amplicon (bp) | Reference |
| (F) CACCAGTACGTCATCCACAA | 136 | [ | |
| (R) GTCTTCTCGCCTTCCAGAAT | |||
| (F) CCGACGAGTGGAGAAATCTGT | 99 | [ | |
| (R) GGAGGTAGCCCTCGATCACT | |||
| (F) GCTCAGCCTGCTGCTGGT | 196 | [ | |
| (R) GGATCTCTTCCATCAGCCACTC | |||
| (F) TGTCCCCACCCCCAATGTATC | 100 | [ | |
| (R) CTCCGATGCCTGCTTCACTACCTT |
¶INSR, Insulin receptor; ‡IGF-1R, Insulin-like growth factor-1 receptor; §IGF-2R, Insulin-like growth factor-2 receptor; * GAPDH, Glyceraldehyde 3-phosphate dehydrogenase.
The effect of IGF-1 supplementation on the nuclear maturation of canine oocytes
| Concentration of IGF-1 (µg/ml) | No of oocytes cultured | Meiotic stage of oocytes (%) † | Total | No. of oocytes degenerated | |||
| GV | GVBD | MI | MII | ||||
| 0 | 152 | 10 (7.2) | 52 (37.7) | 74 (53.6) | 3 (2.2) a | 139 | 13 |
| 0.5 | 97 | 15 (16.0) | 45 (47.9) | 29 (30.9) | 5 (5.3) a | 94 | 3 |
| 5 | 89 | 7 (8.5) | 43 (52.4) | 24 (29.3) | 8 (9.8) ab | 82 | 7 |
| 10 | 96 | 6 (6.7) | 24 (26.7) | 48 (53.3) | 12 (13.3) ab | 90 | 6 |
| 50 | 77 | 11 (14.9) | 30 (40.5) | 24 (32.4) | 9 (12.2) b | 74 | 3 |
† %: No. of oocytes at each meiotic stage / No. of surviving oocytes. GV, germinal vesicle; GVBD, germinal vesicle breakdown; MI, metaphase I; MII, metaphase II.
Fig. 2.Morphology of canine COCs after 48 h of in vitro maturation, showing cumulus cell expansion in the presence of IGF-1. (A) No IGF-1; (B) 0.5 µg/ml IGF-1; (C) 5 µg/ml IGF-1; (D) 50 µg/ml IGF-1.
Fig. 3.Relative expression level of mRNA of IGF-1R, IGF-2R, and INSR in canine oocytes (A) and cumulus cells (B), as detected by quantitative reverse transcription polymerase chain reaction (RT-qPCR) and normalized with glyceraldehyde 3-phosphate dehydrogenase (GAPDH). * IGF-1R, Insulin-like growth factor-1 receptor; IGF-2R, Insulin-like growth factor-2 receptor; INSR, Insulin receptor.
The effect of bpV supplementation on the nuclear maturation of canine oocytes
| Concentration of bpV (µmol/l) | No of oocytes cultured | Meiotic stage of oocytes (%) † | Total | No. of oocytes degenerated | |||
| GV | GVBD | MI | MII | ||||
| 0 | 108 | 1 (1.0) | 41 (39.8) | 51 (49.5) | 10 (9.7) | 103 | 5 |
| 0.2 | 58 | 1 (1.8) | 26 (45.6) | 28 (49.1) | 2 (3.5) | 57 | 1 |
| 1 | 52 | 1 (2.0) | 23 (46.0) | 23 (46.0) | 3 (6.0) | 50 | 2 |
| 5 | 123 | 1 (8.2) | 55 (45.1) | 60 (49.2) | 6 (4.9) | 122 | 1 |
| 20 | 72 | 0 (0) | 24 (33.8) | 45 (63.3) | 2 (2.8) | 71 | 1 |
| 100 | 85 | 0 (0) | 36 (42.9) | 38 (45.2) | 10 (11.9) | 84 | 1 |
| 200 | 65 | 0 (0) | 32 (59.3) | 15 (27.8) | 7 (13.0) | 54 | 11 |
† %: No. of oocytes at each meiotic stage / No. of surviving oocytes. GV, germinal vesicle; GVBD, germinal vesicle breakdown; MI, metaphase I; MII, metaphase II.